Financials in USD. Standardized financial statements.
A compact view of how NeuroOne Medical Technologies Corporation turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $12.10M | $3.45M | $1.95M | $171,169 | $178,146 | $1.93M | $0 | $0 | $0 | $0 |
| Revenue Growth? | +250.4% | +76.9% | +1040.7% | -3.9% | -90.8% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $3.96M | $2.37M | $1.50M | $241,963 | $275,895 | $70,552 | $27,569 | $21,667 | $17,633 | $7,740 |
| Gross Profit? | $8.14M | $1.08M | $456,517 | -$70,794 | -$97,749 | $1.86M | -$27,569 | -$21,667 | -$17,633 | -$7,740 |
| Gross Margin? | +67.3% | +31.3% | +23.4% | -41.4% | -54.9% | +96.3% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses? | $12.37M | $12.97M | $12.41M | $9.96M | $10.12M | $6.76M | $5.81M | $3.19M | $3.07M | $32,611 |
| Operating Income? | -$4.23M | -$11.89M | -$11.96M | -$10.03M | -$10.22M | -$4.90M | -$5.81M | -$3.21M | -$3.07M | -$32,611 |
| EBITDA? | -$3.01M | -$11.84M | -$11.76M | -$9.91M | -$9.80M | -$4.85M | -$5.79M | -$4.15M | -$3.05M | -$32,611 |
| Income Before Tax | -$3.61M | -$12.32M | -$11.86M | -$10.00M | -$9.95M | -$13.64M | -$6.78M | -$6.83M | -$5.06M | -$32,611 |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3 | $0 | $15,164 |
| Net Income? | -$3.61M | -$12.32M | -$11.86M | -$10.00M | -$9.95M | -$13.64M | -$6.78M | -$6.83M | -$5.06M | -$47,775 |
| EPS? | $-0.54 | $-2.76 | $-3.90 | $-3.78 | $-5.58 | $-15.12 | $-10.32 | $-14.58 | $-13.80 | $-0.17 |
| Diluted EPS? | $-0.54 | $-2.76 | $-3.90 | $-3.78 | $-5.58 | $-15.12 | $-10.32 | $-14.58 | $-13.80 | $-0.17 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality